NasdaqGS - Nasdaq Real Time Price • USD
Boundless Bio, Inc. (BOLD)
At close: 4:00 PM EDT
After hours: 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2019) | Next Qtr. (Mar 2020) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.84 | -1.13 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2019) | Next Qtr. (Mar 2020) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| No. of Analysts | 10 | 7 | 12 | 12 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2018 | 3/31/2019 | 6/30/2019 | 9/30/2019 |
|---|---|---|---|---|
| EPS Est. | -0.91 | -0.89 | -1.04 | -1.07 |
| EPS Actual | -0.84 | -1.13 | -1.01 | -1 |
| Difference | 0.07 | -0.24 | 0.03 | 0.07 |
| Surprise % | 7.70% | -27.00% | 2.90% | 6.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2019) | Next Qtr. (Mar 2020) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -1.04 | -1.08 | -4.17 | -4.24 |
| 30 Days Ago | -1.04 | -1.08 | -4.17 | -4.24 |
| 60 Days Ago | -1.04 | -1.08 | -4.17 | -4.24 |
| 90 Days Ago | -1.04 | -1.08 | -4.17 | -4.24 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2019) | Next Qtr. (Mar 2020) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BOLD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 2.60% |
| Next Qtr. | -- | -- | -- | 13.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | 13.20% | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Leerink Partners: Outperform | 4/22/2024 |
| Initiated | Guggenheim: Buy | 4/22/2024 |
| Initiated | Piper Sandler: Overweight | 4/22/2024 |
Related Tickers
ANRO Alto Neuroscience, Inc.
14.13
-0.49%
CTNM Contineum Therapeutics, Inc.
15.99
+0.38%
NMRA Neumora Therapeutics, Inc.
9.06
-5.53%
CGEM Cullinan Therapeutics, Inc.
19.25
+1.91%
AVBP ArriVent BioPharma, Inc.
15.54
+1.57%
TRML Tourmaline Bio, Inc.
16.00
+3.83%
MGX Metagenomi, Inc.
6.74
-0.15%
PEPG PepGen Inc.
11.70
-1.10%
NBTX Nanobiotix S.A.
5.91
+0.17%
TYRA Tyra Biosciences, Inc.
15.11
-5.56%